If you had gestational diabetes, ask your provider about starting GLP-1 therapy as part of a broader type 2 diabetes prevention strategy, not just a weight loss plan
Our Success Stories* Physicians Marketing Solutions Inc
They can assess your labs, review your history, and help you weigh the potential benefits against any risks
Valproate-induced hyperammonemic encephalopathy enhanced by topiramate and phenobarbitone: a case report and an update
While phage cocktails and broader therapeutic frameworks have been extensively explored for the eradication of enteric pathogens and multispecies biofilms, current evidence remains largely concentrated in the preclinical and proof-of-concept stages
Lilly's strategic pivots are evident in this investment: a strong move towards domestic manufacturing reshoring to mitigate tariff risks and enhance supply chain security, a deep focus on complex biologics like ADCs that require specialized infrastructure, and a clear commitment to leveraging advanced technology for "smart manufacturing." The bioconjugate platform also offers flexibility, allowing the facility to adapt to future generations of ADCs or novel bioconjugate therapies
